Clinical trial
Split-Face Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
NCT01046396 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Split-Face Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
- Lead sponsor
- Galderma R&D
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- February 28, 2010
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.